These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38299859)

  • 1. Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open-label feasibility study.
    Said O; Sengun Filiz E; Stringer D; Applewhite B; Kellermann V; Mutwalli H; Bektas S; Akkese MN; Kumar A; Carter B; Simic M; Sually D; Bentley J; Young AH; Madden S; Byford S; Landau S; Lawrence V; Treasure J; Schmidt U; Nicholls D; Himmerich H
    Eur Eat Disord Rev; 2024 May; 32(3):532-546. PubMed ID: 38299859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.
    Gowers SG; Clark AF; Roberts C; Byford S; Barrett B; Griffiths A; Edwards V; Bryan C; Smethurst N; Rowlands L; Roots P
    Health Technol Assess; 2010 Mar; 14(15):1-98. PubMed ID: 20334748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.
    Hay PJ; Touyz S; Claudino AM; Lujic S; Smith CA; Madden S
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010827. PubMed ID: 30663033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
    Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
    BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost-effectiveness of a 'stepping into day treatment' approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trial.
    Irish M; Dalton B; Potts L; McCombie C; Shearer J; Au K; Kern N; Clark-Stone S; Connan F; Johnston AL; Lazarova S; Macdonald S; Newell C; Pathan T; Wales J; Cashmore R; Marshall S; Arcelus J; Robinson P; Himmerich H; Lawrence VC; Treasure J; Byford S; Landau S; Schmidt U
    Trials; 2022 Jun; 23(1):500. PubMed ID: 35710394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPEAKS study: study protocol of a multisite feasibility trial of the Specialist Psychotherapy with Emotion for Anorexia in Kent and Sussex (SPEAKS) intervention for outpatients with anorexia nervosa or otherwise specified feeding and eating disorders, anorexia nervosa type.
    Oldershaw A; Lavender T; Basra R; Startup H
    BMJ Open; 2022 Feb; 12(2):e050350. PubMed ID: 35193902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled feasibility trial of intermittent theta burst stimulation with an open longer-term follow-up for young people with persistent anorexia nervosa (RaISE): Study protocol.
    Hemmings A; Gallop L; İnce B; Cutinha D; Kan C; Simic M; Zadeh E; Malvisi I; McKenzie K; Zocek L; Sharpe H; O'Daly O; Campbell IC; Schmidt U
    Eur Eat Disord Rev; 2024 May; 32(3):575-588. PubMed ID: 38303559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
    Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD
    Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic effects on anthropometric outcomes in anorexia nervosa: a retrospective chart review of hospitalized children and adolescents.
    Frank B; Arnold S; Jaite C; Correll CU
    J Eat Disord; 2023 Sep; 11(1):151. PubMed ID: 37674209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
    Jones AP; Clayton D; Nkhoma G; Sherratt FC; Peak M; Stones SR; Roper L; Young B; McErlane F; Moitt T; Ramanan AV; Foster HE; Williamson PR; Deepak S; Beresford MW; Baildam EM
    Health Technol Assess; 2020 Jul; 24(36):1-152. PubMed ID: 32758350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of olanzapine in the treatment of anorexia nervosa.
    Dunican KC; DelDotto D
    Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of antipsychotics and antidepressants in the treatment of anorexia nervosa: a systematic review.
    Márquez MC; Sánchez JM; Salazar AM; Martínez CV; Valderrama F; Rojas-Gualdrón DF
    Rev Colomb Psiquiatr (Engl Ed); 2022; 51(3):227-235. PubMed ID: 36085125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
    Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
    Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review.
    Thorey S; Blanchet C; Guessoum SB; Moro MR; Ludot M; Carretier E
    PLoS One; 2023; 18(3):e0278189. PubMed ID: 36928656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open trial of olanzapine in anorexia nervosa.
    Barbarich NC; McConaha CW; Gaskill J; La Via M; Frank GK; Achenbach S; Plotnicov KH; Kaye WH
    J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in the treatment of anorexia nervosa: an open label trial.
    Powers PS; Santana CA; Bannon YS
    Int J Eat Disord; 2002 Sep; 32(2):146-54. PubMed ID: 12210656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT.
    Hughes E; Mitchell N; Gascoyne S; Moe-Byrne T; Edmondson A; Coleman E; Millett L; Ali S; Dare C; Hewitt C; Johnson S; Llewellyn C; Mercer C; Nolan F; Walker C; Watson J
    Health Technol Assess; 2019 Dec; 23(65):1-136. PubMed ID: 31854292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics and anorexia nervosa: a review.
    McKnight RF; Park RJ
    Eur Eat Disord Rev; 2010 Jan; 18(1):10-21. PubMed ID: 20054875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H; Tasca GA; Barber AM; Bradwejn J
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.